TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line

被引:6
|
作者
Arisawa, C [1 ]
Kageyama, Y [1 ]
Kawakami, S [1 ]
Kihara, K [1 ]
机构
[1] Tokyo Med & Dent Univ, Grad Sch, Dept Urol & Reprod Med, Bunkyo Ku, Tokyo 1138519, Japan
来源
UROLOGIC ONCOLOGY | 2002年 / 7卷 / 06期
关键词
angiogenesis; inhibitor; prostate; neoplasm;
D O I
10.1016/S1078-1439(02)00195-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined effects of TNP-470 with or without nicardipine on in vivo or in vitro growth of a hormone-independent human prostate carcinoma cell line, PC-3. TNP-470 (30 mg/kg, daily) or nicardipine (25 mug/kg, daily) alone had little effects on in vivo growth of PC-3 cells in Dude mice, whereas simultaneous administration of both agents significantly inhibited the growth of the xenografts. In vitro proliferarion of PC-3 was not affected by TNP-470 and/or nicardipin. Combination of TNP-470 and nicardipine seems beneficial in the treatment of hormone-refractory prostate cancer. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 50 条
  • [11] The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice
    Vijayakumar, S
    Garcia, D
    Hensel, CH
    Banerjee, M
    Bracht, T
    Xiang, RH
    Kagan, J
    Naylor, SL
    GENES CHROMOSOMES & CANCER, 2005, 44 (04): : 365 - 372
  • [12] Combined effects of TNP-470 and taxol in human non-small cell lung cancer cell lines
    Satoh, H
    Ishikawa, H
    Fujimoto, M
    Fujiwara, M
    Yamashita, YT
    Yazawa, T
    Ohtsuka, M
    Hasegawa, S
    Kamma, H
    ANTICANCER RESEARCH, 1998, 18 (2A) : 1027 - 1030
  • [13] Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth -: Discussion
    Brennan, MF
    Hotz, H
    Howard, JM
    JOURNAL OF GASTROINTESTINAL SURGERY, 2001, 5 (02) : 138 - 138
  • [14] EXPERIMENTAL STUDY OF THE EFFECT OF ANGIOGENESISINHIBITOR TNP-470 ON THE GROWTH AND METASTASISOF GASTRIC CANCER IN VIVO
    刘炳亚
    林言箴
    尹浩然
    王瑞年
    朱正刚
    顾琴龙
    ChineseJournalofCancerResearch, 1999, (01) : 3 - 5
  • [15] The angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
    Hotz, HG
    Reber, HA
    Hotz, B
    Sanghavi, PC
    Yu, T
    Foitzik, T
    Buhr, HJ
    Hines, OJ
    GASTROENTEROLOGY, 2000, 118 (04) : A1059 - A1059
  • [16] Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction
    Xiao, Dong
    Lew, Karen L.
    Kim, Young-Ae
    Zeng, Yan
    Hahm, Eun-Ryeong
    Dhir, Rajiv
    Singh, Shivendra V.
    CLINICAL CANCER RESEARCH, 2006, 12 (22) : 6836 - 6843
  • [17] Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo
    Singh, Y
    Shikata, N
    Kiyozuka, Y
    Nambu, H
    Morimoto, J
    Kurebayashi, J
    Hioki, K
    Tsubura, A
    BREAST CANCER RESEARCH AND TREATMENT, 1997, 45 (01) : 15 - 27
  • [18] Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo
    Yogendra Singh
    Nobuaki Shikata
    Yasuhiko Kiyozuka
    Hiroyuki Nambu
    Junji Morimoto
    Junichi Kurebayashi
    Koshiro Hioki
    Airo Tsubura
    Breast Cancer Research and Treatment, 1997, 45 : 15 - 27
  • [19] Proteomic Analysis of Microvesicles Released by the Human Prostate Cancer Cell Line PC-3
    Sandvig, Kirsten
    Llorente, Alicia
    MOLECULAR & CELLULAR PROTEOMICS, 2012, 11 (07)
  • [20] DETERMINATION OF THE CELL VIABILITY IN HUMAN PROSTATE CANCER PC-3 CELL LINE BY SIDERITIS HYSSOPIFOLIA
    Vieitez, J. J. G.
    Vega, M. S.
    Nelida Fernandez, M. M.
    Diez Liebana, Jose M.
    Sahagun Prieto, A. M.
    Laiz, R. D.
    Mananes, V. H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 50 - 50